nodes	percent_of_prediction	percent_of_DWPC	metapath
Enalapril—SLC22A7—Methotrexate—muscle cancer	0.156	0.212	CbGbCtD
Enalapril—SLCO1A2—Methotrexate—muscle cancer	0.11	0.149	CbGbCtD
Enalapril—SLC22A8—Methotrexate—muscle cancer	0.0955	0.13	CbGbCtD
Enalapril—ABCB1—Dactinomycin—muscle cancer	0.0795	0.108	CbGbCtD
Enalapril—SLC22A6—Methotrexate—muscle cancer	0.0665	0.0904	CbGbCtD
Enalapril—ABCB1—Vincristine—muscle cancer	0.0489	0.0665	CbGbCtD
Enalapril—ABCB1—Etoposide—muscle cancer	0.0448	0.0609	CbGbCtD
Enalapril—ABCB1—Doxorubicin—muscle cancer	0.0306	0.0416	CbGbCtD
Enalapril—ABCB1—Methotrexate—muscle cancer	0.0296	0.0403	CbGbCtD
Enalapril—CYP3A4—Vincristine—muscle cancer	0.0293	0.0398	CbGbCtD
Enalapril—CYP3A4—Etoposide—muscle cancer	0.0269	0.0365	CbGbCtD
Enalapril—ACE—forelimb zeugopod—muscle cancer	0.0192	0.248	CbGeAlD
Enalapril—CYP3A4—Doxorubicin—muscle cancer	0.0183	0.0249	CbGbCtD
Enalapril—ACE—hindlimb—muscle cancer	0.00871	0.112	CbGeAlD
Enalapril—ACE—arm—muscle cancer	0.00832	0.107	CbGeAlD
Enalapril—ACE—appendage—muscle cancer	0.00747	0.0964	CbGeAlD
Enalapril—SLC22A7—renal system—muscle cancer	0.00326	0.042	CbGeAlD
Enalapril—SLC15A1—renal system—muscle cancer	0.00262	0.0338	CbGeAlD
Enalapril—ACE—embryo—muscle cancer	0.00248	0.032	CbGeAlD
Enalapril—SLC22A7—testis—muscle cancer	0.00211	0.0272	CbGeAlD
Enalapril—SLCO1A2—renal system—muscle cancer	0.00197	0.0255	CbGeAlD
Enalapril—ACE—smooth muscle tissue—muscle cancer	0.00195	0.0252	CbGeAlD
Enalapril—SLC15A1—vagina—muscle cancer	0.0019	0.0245	CbGeAlD
Enalapril—SLC22A8—renal system—muscle cancer	0.00188	0.0243	CbGeAlD
Enalapril—ACE—renal system—muscle cancer	0.00188	0.0242	CbGeAlD
Enalapril—ACE—cardiac atrium—muscle cancer	0.00168	0.0217	CbGeAlD
Enalapril—ACE—bone marrow—muscle cancer	0.00142	0.0183	CbGeAlD
Enalapril—SLCO1A2—head—muscle cancer	0.00132	0.017	CbGeAlD
Enalapril—SLCO1A2—testis—muscle cancer	0.00128	0.0165	CbGeAlD
Enalapril—SLC22A8—head—muscle cancer	0.00126	0.0163	CbGeAlD
Enalapril—ACE—head—muscle cancer	0.00126	0.0162	CbGeAlD
Enalapril—ACE—testis—muscle cancer	0.00121	0.0157	CbGeAlD
Enalapril—CYP3A4—renal system—muscle cancer	0.000934	0.012	CbGeAlD
Enalapril—ABCB1—embryo—muscle cancer	0.000873	0.0113	CbGeAlD
Enalapril—ABCB1—renal system—muscle cancer	0.000661	0.00853	CbGeAlD
Enalapril—Alopecia—Etoposide—muscle cancer	0.000546	0.00293	CcSEcCtD
Enalapril—Cerebrovascular accident—Methotrexate—muscle cancer	0.000546	0.00293	CcSEcCtD
Enalapril—Oedema—Vincristine—muscle cancer	0.000541	0.00291	CcSEcCtD
Enalapril—Anaphylactic shock—Vincristine—muscle cancer	0.000541	0.00291	CcSEcCtD
Enalapril—Thrombocytopenia—Vincristine—muscle cancer	0.00053	0.00284	CcSEcCtD
Enalapril—Photosensitivity—Doxorubicin—muscle cancer	0.000527	0.00283	CcSEcCtD
Enalapril—Decreased appetite—Dactinomycin—muscle cancer	0.000527	0.00283	CcSEcCtD
Enalapril—Dysgeusia—Etoposide—muscle cancer	0.000526	0.00282	CcSEcCtD
Enalapril—Hyperhidrosis—Vincristine—muscle cancer	0.000523	0.00281	CcSEcCtD
Enalapril—Fatigue—Dactinomycin—muscle cancer	0.000523	0.0028	CcSEcCtD
Enalapril—Back pain—Etoposide—muscle cancer	0.00052	0.00279	CcSEcCtD
Enalapril—Muscle spasms—Etoposide—muscle cancer	0.000517	0.00277	CcSEcCtD
Enalapril—Anorexia—Vincristine—muscle cancer	0.000516	0.00277	CcSEcCtD
Enalapril—Hepatic failure—Doxorubicin—muscle cancer	0.000515	0.00276	CcSEcCtD
Enalapril—Irritability—Methotrexate—muscle cancer	0.00051	0.00274	CcSEcCtD
Enalapril—Hypotension—Vincristine—muscle cancer	0.000506	0.00271	CcSEcCtD
Enalapril—Ataxia—Methotrexate—muscle cancer	0.000503	0.0027	CcSEcCtD
Enalapril—ABCB1—bone marrow—muscle cancer	0.0005	0.00645	CbGeAlD
Enalapril—Feeling abnormal—Dactinomycin—muscle cancer	0.000499	0.00268	CcSEcCtD
Enalapril—Anaemia—Etoposide—muscle cancer	0.000497	0.00267	CcSEcCtD
Enalapril—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000496	0.00266	CcSEcCtD
Enalapril—Hot flush—Doxorubicin—muscle cancer	0.000495	0.00266	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000493	0.00265	CcSEcCtD
Enalapril—Menopausal symptoms—Doxorubicin—muscle cancer	0.000491	0.00263	CcSEcCtD
Enalapril—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.000491	0.00263	CcSEcCtD
Enalapril—Insomnia—Vincristine—muscle cancer	0.00049	0.00263	CcSEcCtD
Enalapril—Paraesthesia—Vincristine—muscle cancer	0.000486	0.00261	CcSEcCtD
Enalapril—Vertigo—Etoposide—muscle cancer	0.000483	0.00259	CcSEcCtD
Enalapril—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.000481	0.00258	CcSEcCtD
Enalapril—Leukopenia—Etoposide—muscle cancer	0.000481	0.00258	CcSEcCtD
Enalapril—Abdominal pain—Dactinomycin—muscle cancer	0.000479	0.00257	CcSEcCtD
Enalapril—Body temperature increased—Dactinomycin—muscle cancer	0.000479	0.00257	CcSEcCtD
Enalapril—ABCB1—vagina—muscle cancer	0.000479	0.00618	CbGeAlD
Enalapril—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.000478	0.00257	CcSEcCtD
Enalapril—Hypoglycaemia—Doxorubicin—muscle cancer	0.000474	0.00255	CcSEcCtD
Enalapril—Loss of consciousness—Etoposide—muscle cancer	0.000472	0.00253	CcSEcCtD
Enalapril—Cerebrovascular accident—Doxorubicin—muscle cancer	0.000472	0.00253	CcSEcCtD
Enalapril—Decreased appetite—Vincristine—muscle cancer	0.000471	0.00253	CcSEcCtD
Enalapril—Cough—Etoposide—muscle cancer	0.000469	0.00252	CcSEcCtD
Enalapril—Fatigue—Vincristine—muscle cancer	0.000467	0.00251	CcSEcCtD
Enalapril—Hyponatraemia—Doxorubicin—muscle cancer	0.000465	0.00249	CcSEcCtD
Enalapril—Constipation—Vincristine—muscle cancer	0.000463	0.00248	CcSEcCtD
Enalapril—Pain in extremity—Doxorubicin—muscle cancer	0.000463	0.00248	CcSEcCtD
Enalapril—Asthma—Methotrexate—muscle cancer	0.000462	0.00248	CcSEcCtD
Enalapril—Chest pain—Etoposide—muscle cancer	0.000458	0.00246	CcSEcCtD
Enalapril—Eosinophilia—Methotrexate—muscle cancer	0.000457	0.00245	CcSEcCtD
Enalapril—Pancreatitis—Methotrexate—muscle cancer	0.000453	0.00243	CcSEcCtD
Enalapril—Discomfort—Etoposide—muscle cancer	0.000452	0.00243	CcSEcCtD
Enalapril—Face oedema—Doxorubicin—muscle cancer	0.000447	0.0024	CcSEcCtD
Enalapril—Hypersensitivity—Dactinomycin—muscle cancer	0.000447	0.0024	CcSEcCtD
Enalapril—Gastrointestinal pain—Vincristine—muscle cancer	0.000443	0.00238	CcSEcCtD
Enalapril—Confusional state—Etoposide—muscle cancer	0.000442	0.00237	CcSEcCtD
Enalapril—ABCB1—head—muscle cancer	0.000442	0.0057	CbGeAlD
Enalapril—Cardiac arrest—Doxorubicin—muscle cancer	0.00044	0.00236	CcSEcCtD
Enalapril—Pancytopenia—Methotrexate—muscle cancer	0.000439	0.00235	CcSEcCtD
Enalapril—Anaphylactic shock—Etoposide—muscle cancer	0.000439	0.00235	CcSEcCtD
Enalapril—Ataxia—Doxorubicin—muscle cancer	0.000435	0.00234	CcSEcCtD
Enalapril—Asthenia—Dactinomycin—muscle cancer	0.000435	0.00233	CcSEcCtD
Enalapril—Blood creatinine increased—Doxorubicin—muscle cancer	0.000434	0.00233	CcSEcCtD
Enalapril—Dysuria—Methotrexate—muscle cancer	0.000432	0.00232	CcSEcCtD
Enalapril—Neutropenia—Methotrexate—muscle cancer	0.000432	0.00232	CcSEcCtD
Enalapril—Thrombocytopenia—Etoposide—muscle cancer	0.000429	0.0023	CcSEcCtD
Enalapril—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000429	0.0023	CcSEcCtD
Enalapril—Tachycardia—Etoposide—muscle cancer	0.000428	0.0023	CcSEcCtD
Enalapril—Abdominal pain—Vincristine—muscle cancer	0.000428	0.0023	CcSEcCtD
Enalapril—Body temperature increased—Vincristine—muscle cancer	0.000428	0.0023	CcSEcCtD
Enalapril—ABCB1—testis—muscle cancer	0.000427	0.00551	CbGeAlD
Enalapril—Erectile dysfunction—Methotrexate—muscle cancer	0.000426	0.00228	CcSEcCtD
Enalapril—Dry skin—Doxorubicin—muscle cancer	0.000424	0.00228	CcSEcCtD
Enalapril—Hyperhidrosis—Etoposide—muscle cancer	0.000424	0.00228	CcSEcCtD
Enalapril—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000423	0.00227	CcSEcCtD
Enalapril—Photosensitivity reaction—Methotrexate—muscle cancer	0.000422	0.00226	CcSEcCtD
Enalapril—Anorexia—Etoposide—muscle cancer	0.000418	0.00224	CcSEcCtD
Enalapril—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000417	0.00224	CcSEcCtD
Enalapril—Diarrhoea—Dactinomycin—muscle cancer	0.000415	0.00223	CcSEcCtD
Enalapril—Pneumonia—Methotrexate—muscle cancer	0.000414	0.00222	CcSEcCtD
Enalapril—Nasopharyngitis—Doxorubicin—muscle cancer	0.000414	0.00222	CcSEcCtD
Enalapril—Depression—Methotrexate—muscle cancer	0.000411	0.0022	CcSEcCtD
Enalapril—Hypotension—Etoposide—muscle cancer	0.00041	0.0022	CcSEcCtD
Enalapril—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000408	0.00219	CcSEcCtD
Enalapril—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000408	0.00219	CcSEcCtD
Enalapril—Renal failure—Methotrexate—muscle cancer	0.000405	0.00217	CcSEcCtD
Enalapril—Stomatitis—Methotrexate—muscle cancer	0.000402	0.00215	CcSEcCtD
Enalapril—Conjunctivitis—Methotrexate—muscle cancer	0.0004	0.00215	CcSEcCtD
Enalapril—Asthma—Doxorubicin—muscle cancer	0.0004	0.00215	CcSEcCtD
Enalapril—Dysphagia—Doxorubicin—muscle cancer	0.0004	0.00215	CcSEcCtD
Enalapril—Influenza—Doxorubicin—muscle cancer	0.0004	0.00215	CcSEcCtD
Enalapril—Hypersensitivity—Vincristine—muscle cancer	0.000399	0.00214	CcSEcCtD
Enalapril—Eosinophilia—Doxorubicin—muscle cancer	0.000396	0.00213	CcSEcCtD
Enalapril—Paraesthesia—Etoposide—muscle cancer	0.000394	0.00211	CcSEcCtD
Enalapril—Pancreatitis—Doxorubicin—muscle cancer	0.000392	0.0021	CcSEcCtD
Enalapril—Dyspnoea—Etoposide—muscle cancer	0.000391	0.0021	CcSEcCtD
Enalapril—Somnolence—Etoposide—muscle cancer	0.00039	0.00209	CcSEcCtD
Enalapril—Angina pectoris—Doxorubicin—muscle cancer	0.00039	0.00209	CcSEcCtD
Enalapril—Epistaxis—Methotrexate—muscle cancer	0.000389	0.00208	CcSEcCtD
Enalapril—Asthenia—Vincristine—muscle cancer	0.000388	0.00208	CcSEcCtD
Enalapril—Vomiting—Dactinomycin—muscle cancer	0.000385	0.00207	CcSEcCtD
Enalapril—Bronchitis—Doxorubicin—muscle cancer	0.000385	0.00206	CcSEcCtD
Enalapril—Agranulocytosis—Methotrexate—muscle cancer	0.000384	0.00206	CcSEcCtD
Enalapril—Rash—Dactinomycin—muscle cancer	0.000382	0.00205	CcSEcCtD
Enalapril—Decreased appetite—Etoposide—muscle cancer	0.000381	0.00205	CcSEcCtD
Enalapril—Pancytopenia—Doxorubicin—muscle cancer	0.00038	0.00204	CcSEcCtD
Enalapril—Fatigue—Etoposide—muscle cancer	0.000378	0.00203	CcSEcCtD
Enalapril—Constipation—Etoposide—muscle cancer	0.000375	0.00201	CcSEcCtD
Enalapril—Dysuria—Doxorubicin—muscle cancer	0.000374	0.00201	CcSEcCtD
Enalapril—Neutropenia—Doxorubicin—muscle cancer	0.000374	0.00201	CcSEcCtD
Enalapril—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000372	0.002	CcSEcCtD
Enalapril—Diarrhoea—Vincristine—muscle cancer	0.00037	0.00199	CcSEcCtD
Enalapril—Hepatitis—Methotrexate—muscle cancer	0.00037	0.00198	CcSEcCtD
Enalapril—Pollakiuria—Doxorubicin—muscle cancer	0.00037	0.00198	CcSEcCtD
Enalapril—Pharyngitis—Methotrexate—muscle cancer	0.000367	0.00197	CcSEcCtD
Enalapril—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000365	0.00196	CcSEcCtD
Enalapril—Feeling abnormal—Etoposide—muscle cancer	0.000361	0.00194	CcSEcCtD
Enalapril—Hyperglycaemia—Doxorubicin—muscle cancer	0.000361	0.00194	CcSEcCtD
Enalapril—Nausea—Dactinomycin—muscle cancer	0.00036	0.00193	CcSEcCtD
Enalapril—Pneumonia—Doxorubicin—muscle cancer	0.000359	0.00193	CcSEcCtD
Enalapril—Gastrointestinal pain—Etoposide—muscle cancer	0.000359	0.00192	CcSEcCtD
Enalapril—Dizziness—Vincristine—muscle cancer	0.000358	0.00192	CcSEcCtD
Enalapril—Visual impairment—Methotrexate—muscle cancer	0.000356	0.00191	CcSEcCtD
Enalapril—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000354	0.0019	CcSEcCtD
Enalapril—Renal failure—Doxorubicin—muscle cancer	0.000351	0.00188	CcSEcCtD
Enalapril—Erythema multiforme—Methotrexate—muscle cancer	0.00035	0.00188	CcSEcCtD
Enalapril—Neuropathy peripheral—Doxorubicin—muscle cancer	0.00035	0.00188	CcSEcCtD
Enalapril—Urticaria—Etoposide—muscle cancer	0.000348	0.00187	CcSEcCtD
Enalapril—Stomatitis—Doxorubicin—muscle cancer	0.000348	0.00187	CcSEcCtD
Enalapril—Jaundice—Doxorubicin—muscle cancer	0.000348	0.00187	CcSEcCtD
Enalapril—Abdominal pain—Etoposide—muscle cancer	0.000347	0.00186	CcSEcCtD
Enalapril—Body temperature increased—Etoposide—muscle cancer	0.000347	0.00186	CcSEcCtD
Enalapril—Conjunctivitis—Doxorubicin—muscle cancer	0.000347	0.00186	CcSEcCtD
Enalapril—Urinary tract infection—Doxorubicin—muscle cancer	0.000347	0.00186	CcSEcCtD
Enalapril—Tinnitus—Methotrexate—muscle cancer	0.000345	0.00185	CcSEcCtD
Enalapril—Vomiting—Vincristine—muscle cancer	0.000344	0.00185	CcSEcCtD
Enalapril—Rash—Vincristine—muscle cancer	0.000341	0.00183	CcSEcCtD
Enalapril—Dermatitis—Vincristine—muscle cancer	0.000341	0.00183	CcSEcCtD
Enalapril—Headache—Vincristine—muscle cancer	0.000339	0.00182	CcSEcCtD
Enalapril—Epistaxis—Doxorubicin—muscle cancer	0.000336	0.00181	CcSEcCtD
Enalapril—Sinusitis—Doxorubicin—muscle cancer	0.000335	0.0018	CcSEcCtD
Enalapril—Agranulocytosis—Doxorubicin—muscle cancer	0.000333	0.00179	CcSEcCtD
Enalapril—Alopecia—Methotrexate—muscle cancer	0.000327	0.00175	CcSEcCtD
Enalapril—Bradycardia—Doxorubicin—muscle cancer	0.000326	0.00175	CcSEcCtD
Enalapril—Hypersensitivity—Etoposide—muscle cancer	0.000323	0.00173	CcSEcCtD
Enalapril—Erythema—Methotrexate—muscle cancer	0.000322	0.00173	CcSEcCtD
Enalapril—Nausea—Vincristine—muscle cancer	0.000322	0.00173	CcSEcCtD
Enalapril—Hepatitis—Doxorubicin—muscle cancer	0.00032	0.00172	CcSEcCtD
Enalapril—Pharyngitis—Doxorubicin—muscle cancer	0.000318	0.00171	CcSEcCtD
Enalapril—Dysgeusia—Methotrexate—muscle cancer	0.000315	0.00169	CcSEcCtD
Enalapril—Asthenia—Etoposide—muscle cancer	0.000315	0.00169	CcSEcCtD
Enalapril—Back pain—Methotrexate—muscle cancer	0.000311	0.00167	CcSEcCtD
Enalapril—Pruritus—Etoposide—muscle cancer	0.00031	0.00167	CcSEcCtD
Enalapril—Visual impairment—Doxorubicin—muscle cancer	0.000309	0.00166	CcSEcCtD
Enalapril—Vision blurred—Methotrexate—muscle cancer	0.000303	0.00163	CcSEcCtD
Enalapril—Erythema multiforme—Doxorubicin—muscle cancer	0.000303	0.00162	CcSEcCtD
Enalapril—Diarrhoea—Etoposide—muscle cancer	0.0003	0.00161	CcSEcCtD
Enalapril—Tinnitus—Doxorubicin—muscle cancer	0.000299	0.0016	CcSEcCtD
Enalapril—Anaemia—Methotrexate—muscle cancer	0.000298	0.0016	CcSEcCtD
Enalapril—Flushing—Doxorubicin—muscle cancer	0.000297	0.00159	CcSEcCtD
Enalapril—Dizziness—Etoposide—muscle cancer	0.00029	0.00156	CcSEcCtD
Enalapril—Vertigo—Methotrexate—muscle cancer	0.000289	0.00155	CcSEcCtD
Enalapril—Leukopenia—Methotrexate—muscle cancer	0.000288	0.00155	CcSEcCtD
Enalapril—Arrhythmia—Doxorubicin—muscle cancer	0.000286	0.00153	CcSEcCtD
Enalapril—Alopecia—Doxorubicin—muscle cancer	0.000283	0.00152	CcSEcCtD
Enalapril—Cough—Methotrexate—muscle cancer	0.000281	0.00151	CcSEcCtD
Enalapril—Vomiting—Etoposide—muscle cancer	0.000279	0.0015	CcSEcCtD
Enalapril—Erythema—Doxorubicin—muscle cancer	0.000279	0.0015	CcSEcCtD
Enalapril—Rash—Etoposide—muscle cancer	0.000277	0.00148	CcSEcCtD
Enalapril—Dermatitis—Etoposide—muscle cancer	0.000276	0.00148	CcSEcCtD
Enalapril—Headache—Etoposide—muscle cancer	0.000275	0.00147	CcSEcCtD
Enalapril—Flatulence—Doxorubicin—muscle cancer	0.000275	0.00147	CcSEcCtD
Enalapril—Arthralgia—Methotrexate—muscle cancer	0.000274	0.00147	CcSEcCtD
Enalapril—Chest pain—Methotrexate—muscle cancer	0.000274	0.00147	CcSEcCtD
Enalapril—Myalgia—Methotrexate—muscle cancer	0.000274	0.00147	CcSEcCtD
Enalapril—Tension—Doxorubicin—muscle cancer	0.000274	0.00147	CcSEcCtD
Enalapril—Dysgeusia—Doxorubicin—muscle cancer	0.000273	0.00146	CcSEcCtD
Enalapril—Discomfort—Methotrexate—muscle cancer	0.000271	0.00145	CcSEcCtD
Enalapril—Nervousness—Doxorubicin—muscle cancer	0.000271	0.00145	CcSEcCtD
Enalapril—Back pain—Doxorubicin—muscle cancer	0.00027	0.00145	CcSEcCtD
Enalapril—Muscle spasms—Doxorubicin—muscle cancer	0.000268	0.00144	CcSEcCtD
Enalapril—Confusional state—Methotrexate—muscle cancer	0.000265	0.00142	CcSEcCtD
Enalapril—Anaphylactic shock—Methotrexate—muscle cancer	0.000263	0.00141	CcSEcCtD
Enalapril—Vision blurred—Doxorubicin—muscle cancer	0.000263	0.00141	CcSEcCtD
Enalapril—Nausea—Etoposide—muscle cancer	0.000261	0.0014	CcSEcCtD
Enalapril—Anaemia—Doxorubicin—muscle cancer	0.000258	0.00138	CcSEcCtD
Enalapril—Thrombocytopenia—Methotrexate—muscle cancer	0.000257	0.00138	CcSEcCtD
Enalapril—Agitation—Doxorubicin—muscle cancer	0.000256	0.00137	CcSEcCtD
Enalapril—Hyperhidrosis—Methotrexate—muscle cancer	0.000254	0.00136	CcSEcCtD
Enalapril—Vertigo—Doxorubicin—muscle cancer	0.00025	0.00134	CcSEcCtD
Enalapril—Anorexia—Methotrexate—muscle cancer	0.00025	0.00134	CcSEcCtD
Enalapril—Syncope—Doxorubicin—muscle cancer	0.00025	0.00134	CcSEcCtD
Enalapril—Leukopenia—Doxorubicin—muscle cancer	0.00025	0.00134	CcSEcCtD
Enalapril—Palpitations—Doxorubicin—muscle cancer	0.000246	0.00132	CcSEcCtD
Enalapril—Hypotension—Methotrexate—muscle cancer	0.000246	0.00132	CcSEcCtD
Enalapril—Loss of consciousness—Doxorubicin—muscle cancer	0.000245	0.00131	CcSEcCtD
Enalapril—Cough—Doxorubicin—muscle cancer	0.000243	0.00131	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000239	0.00128	CcSEcCtD
Enalapril—Insomnia—Methotrexate—muscle cancer	0.000238	0.00128	CcSEcCtD
Enalapril—Arthralgia—Doxorubicin—muscle cancer	0.000237	0.00127	CcSEcCtD
Enalapril—Chest pain—Doxorubicin—muscle cancer	0.000237	0.00127	CcSEcCtD
Enalapril—Myalgia—Doxorubicin—muscle cancer	0.000237	0.00127	CcSEcCtD
Enalapril—Paraesthesia—Methotrexate—muscle cancer	0.000236	0.00127	CcSEcCtD
Enalapril—Discomfort—Doxorubicin—muscle cancer	0.000234	0.00126	CcSEcCtD
Enalapril—Dyspnoea—Methotrexate—muscle cancer	0.000234	0.00126	CcSEcCtD
Enalapril—Somnolence—Methotrexate—muscle cancer	0.000234	0.00125	CcSEcCtD
Enalapril—Dry mouth—Doxorubicin—muscle cancer	0.000232	0.00125	CcSEcCtD
Enalapril—Dyspepsia—Methotrexate—muscle cancer	0.000231	0.00124	CcSEcCtD
Enalapril—Confusional state—Doxorubicin—muscle cancer	0.000229	0.00123	CcSEcCtD
Enalapril—Decreased appetite—Methotrexate—muscle cancer	0.000228	0.00123	CcSEcCtD
Enalapril—Anaphylactic shock—Doxorubicin—muscle cancer	0.000228	0.00122	CcSEcCtD
Enalapril—Oedema—Doxorubicin—muscle cancer	0.000228	0.00122	CcSEcCtD
Enalapril—Fatigue—Methotrexate—muscle cancer	0.000227	0.00122	CcSEcCtD
Enalapril—Shock—Doxorubicin—muscle cancer	0.000224	0.0012	CcSEcCtD
Enalapril—Thrombocytopenia—Doxorubicin—muscle cancer	0.000223	0.0012	CcSEcCtD
Enalapril—Tachycardia—Doxorubicin—muscle cancer	0.000222	0.00119	CcSEcCtD
Enalapril—Hyperhidrosis—Doxorubicin—muscle cancer	0.00022	0.00118	CcSEcCtD
Enalapril—Anorexia—Doxorubicin—muscle cancer	0.000217	0.00116	CcSEcCtD
Enalapril—Feeling abnormal—Methotrexate—muscle cancer	0.000217	0.00116	CcSEcCtD
Enalapril—Gastrointestinal pain—Methotrexate—muscle cancer	0.000215	0.00115	CcSEcCtD
Enalapril—Hypotension—Doxorubicin—muscle cancer	0.000213	0.00114	CcSEcCtD
Enalapril—Urticaria—Methotrexate—muscle cancer	0.000209	0.00112	CcSEcCtD
Enalapril—Body temperature increased—Methotrexate—muscle cancer	0.000208	0.00111	CcSEcCtD
Enalapril—Abdominal pain—Methotrexate—muscle cancer	0.000208	0.00111	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000207	0.00111	CcSEcCtD
Enalapril—Insomnia—Doxorubicin—muscle cancer	0.000206	0.0011	CcSEcCtD
Enalapril—Paraesthesia—Doxorubicin—muscle cancer	0.000204	0.0011	CcSEcCtD
Enalapril—Dyspnoea—Doxorubicin—muscle cancer	0.000203	0.00109	CcSEcCtD
Enalapril—Somnolence—Doxorubicin—muscle cancer	0.000202	0.00109	CcSEcCtD
Enalapril—Dyspepsia—Doxorubicin—muscle cancer	0.0002	0.00107	CcSEcCtD
Enalapril—Decreased appetite—Doxorubicin—muscle cancer	0.000198	0.00106	CcSEcCtD
Enalapril—Fatigue—Doxorubicin—muscle cancer	0.000196	0.00105	CcSEcCtD
Enalapril—Constipation—Doxorubicin—muscle cancer	0.000195	0.00104	CcSEcCtD
Enalapril—Hypersensitivity—Methotrexate—muscle cancer	0.000194	0.00104	CcSEcCtD
Enalapril—Asthenia—Methotrexate—muscle cancer	0.000189	0.00101	CcSEcCtD
Enalapril—Feeling abnormal—Doxorubicin—muscle cancer	0.000187	0.00101	CcSEcCtD
Enalapril—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000186	0.000998	CcSEcCtD
Enalapril—Pruritus—Methotrexate—muscle cancer	0.000186	0.000997	CcSEcCtD
Enalapril—Urticaria—Doxorubicin—muscle cancer	0.000181	0.00097	CcSEcCtD
Enalapril—Abdominal pain—Doxorubicin—muscle cancer	0.00018	0.000965	CcSEcCtD
Enalapril—Body temperature increased—Doxorubicin—muscle cancer	0.00018	0.000965	CcSEcCtD
Enalapril—Diarrhoea—Methotrexate—muscle cancer	0.00018	0.000965	CcSEcCtD
Enalapril—Dizziness—Methotrexate—muscle cancer	0.000174	0.000932	CcSEcCtD
Enalapril—Hypersensitivity—Doxorubicin—muscle cancer	0.000168	0.000899	CcSEcCtD
Enalapril—Vomiting—Methotrexate—muscle cancer	0.000167	0.000896	CcSEcCtD
Enalapril—Rash—Methotrexate—muscle cancer	0.000166	0.000889	CcSEcCtD
Enalapril—Dermatitis—Methotrexate—muscle cancer	0.000166	0.000888	CcSEcCtD
Enalapril—Headache—Methotrexate—muscle cancer	0.000165	0.000883	CcSEcCtD
Enalapril—Asthenia—Doxorubicin—muscle cancer	0.000163	0.000876	CcSEcCtD
Enalapril—Pruritus—Doxorubicin—muscle cancer	0.000161	0.000864	CcSEcCtD
Enalapril—Nausea—Methotrexate—muscle cancer	0.000156	0.000837	CcSEcCtD
Enalapril—Diarrhoea—Doxorubicin—muscle cancer	0.000156	0.000835	CcSEcCtD
Enalapril—Dizziness—Doxorubicin—muscle cancer	0.00015	0.000807	CcSEcCtD
Enalapril—Vomiting—Doxorubicin—muscle cancer	0.000145	0.000776	CcSEcCtD
Enalapril—Rash—Doxorubicin—muscle cancer	0.000143	0.00077	CcSEcCtD
Enalapril—Dermatitis—Doxorubicin—muscle cancer	0.000143	0.000769	CcSEcCtD
Enalapril—Headache—Doxorubicin—muscle cancer	0.000143	0.000765	CcSEcCtD
Enalapril—Nausea—Doxorubicin—muscle cancer	0.000135	0.000725	CcSEcCtD
